CCR5 and Parkinson disease: A later study with a mouse model of Parkinson's disease further demonstrated that CCR5 deficiency resulted in lower numbers of dopamine neurons, reduced levels of striatal dopamine, and decreased locomotor activity (29), indicating that the CCL5/CCR5 pathway plays an important role in maintaining striatal dopamine levels by promoting neuron survival.